Skip to content

Effects of Trophectoderm (TE) Biopsy on the Health and Development of Children Born After Preimplantation Genetic Testing (PGT) Cycles.

A Prospective Observational Study of the Impact of Blastocyst Biopsy on Postnatal Growth in Children Born After Preimplantation Genetic Testing

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07349966
Enrollment
330
Registered
2026-01-20
Start date
2026-03-19
Completion date
2028-10-27
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assisted Reproduction Technologies, Frozen Embryo Transfer Cycle, Postnatal Health, Preimplantation Genetic Testing (PGT)

Keywords

ART, PGT, FET

Brief summary

This study aims to investigate the effects of trophectoderm (TE) biopsy on the health and development of children born after preimplantation genetic testing (PGT) cycles. The blastocyst biopsy is performed as part of standard clinical practice, in accordance with established protocols and current national regulations governing assisted reproduction.

Interventions

OTHERQuestionnaire

The only additional procedure involved in this study is the administration of a questionnaire to the parents, which is not part of routine clinical follow-up. The questionnaire was originally developed in the context of the Norwegian Mother and Child Cohort Study (MoBa).

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Months
Healthy volunteers
Yes

Inclusion criteria

for Cases: * Child: Has completed the first year of life at the time of data collection. * Child: Does not have any pre-existing medical conditions that significantly affect growth (weight and height). * Mother: Able to provide informed consent for participation in the study. * Mother: Conceived between the ages of 18 and 43. * Mother: Achieved a singleton live birth with a single gestational sac. * Mother: Underwent a PGT cycle followed by FET. Inclusion Criteria for Controls: * Child: Has completed the first year of life at the time of data collection. * Child: Does not have any pre-existing medical conditions that significantly affect growth (weight and height). * Mother: Able to provide informed consent for participation in the study. * Mother: Conceived between the ages of 18 and 43. * Mother: Achieved a singleton live birth with a single gestational sac. * Mother: Underwent only FET. Participants will be excluded from this study if they meet any of the following criteria: * Mother: Unable or unwilling to sign the informed consent. * Mother: Has undergone a fresh embryo transfer. * Child: Missing birth weight or length/height data.

Design outcomes

Primary

MeasureTime frameDescription
Impact of Blastocyst Biopsy on Postnatal Growth at One Year12 months of life of childrenQuestionnaire

Secondary

MeasureTime frameDescription
Long-Term Growth After Blastocyst BiopsyAt birth of children and at 60 months of ageQuestionnaire

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORENRICO PAPALEO, MD

IRCCS San Raffaele

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026